(SXRM) iShares VII - iShares - Ratings and Ratios
US Treasury Bonds, Government Securities, Fixed Income
Description: SXRM iShares VII - iShares
The iShares VII PLC - iShares $ Treasury Bd7-10y ETF USD Acc (XETRA:SXRM) is an exchange-traded fund (ETF) that tracks the Morningstar US Govt Bd TR USD index, providing exposure to US government bonds with maturities between 7 and 10 years. As a USD Government Bond ETF, it is designed to offer investors a stable source of returns with low volatility.
With Assets Under Management (AUM) of approximately $3.92 billion USD, the fund has a significant presence in the market. The ETFs investment objective is to replicate the performance of the underlying index, which is comprised of US Treasury bonds with a specific maturity profile. This allows investors to gain targeted exposure to a specific segment of the yield curve.
To evaluate the ETFs performance, key metrics such as tracking error, yield, and duration can be considered. A low tracking error would indicate that the ETF is effectively replicating the index, while a higher yield would suggest a more attractive return profile. Additionally, the ETFs duration, which measures its sensitivity to interest rate changes, is likely to be around 7-10 years, given its maturity profile. Investors can use these metrics to assess the ETFs potential to meet their investment objectives.
From a technical analysis perspective, the ETFs price action can be evaluated using indicators such as the Relative Strength Index (RSI) and Bollinger Bands. However, based on the provided data, the ETFs price is currently above its 20-day, 50-day, and 200-day Simple Moving Averages (SMA), indicating a positive trend. The Average True Range (ATR) of 0.61, representing a 0.41% daily price range, suggests relatively low volatility.
Additional Sources for SXRM ETF
SXRM ETF Overview
Market Cap in USD | 3,916m |
Category | USD Government Bond |
TER | 0.07% |
IPO / Inception | 2009-06-03 |
SXRM ETF Ratings
Growth Rating | -25.6 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 7.74 |
Analysts | - |
Fair Price Momentum | 136.76 USD |
Fair Price DCF | - |
SXRM Dividends
Currently no dividends paidSXRM Growth Ratios
Growth Correlation 3m | 49.9% |
Growth Correlation 12m | 19.8% |
Growth Correlation 5y | -63.4% |
CAGR 5y | -2.68% |
CAGR/Max DD 5y | -0.12 |
Sharpe Ratio 12m | 0.40 |
Alpha | 0.31 |
Beta | -0.142 |
Volatility | 6.10% |
Current Volume | 0.8k |
Average Volume 20d | 1.1k |
Stop Loss | 143.3 (-3.5%) |
As of July 09, 2025, the stock is trading at USD 148.51 with a total of 751 shares traded.
Over the past week, the price has changed by -0.94%, over one month by +0.94%, over three months by -0.03% and over the past year by +4.20%.
Probably not. Based on ValueRay´s Analyses, iShares VII - iShares (XETRA:SXRM) is currently (July 2025) not a good stock to buy. It has a ValueRay Growth Rating of -25.63 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SXRM is around 136.76 USD . This means that SXRM is currently overvalued and has a potential downside of -7.91%.
iShares VII - iShares has no consensus analysts rating.
According to our own proprietary Forecast Model, SXRM iShares VII - iShares will be worth about 147.7 in July 2026. The stock is currently trading at 148.51. This means that the stock has a potential downside of -0.55%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 147.7 | -0.5% |